Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

News and Insights

Showing items 1 to3 of 6

Playlist Category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Take: Insurers continue to reap profits, announce acquisitions in Q1
Insight
Our Take Newsletter
April 26, 2021

Our Take: Insurers continue to reap profits, announce acquisitions in Q1

Learn More
April 26, 2021
Health policy, CMS initiatives and health economics
Our Take: Humana to buy remaining stake in Kindred at home for $5.7 billion
Insight
Our Take Newsletter
May 3, 2021

Our Take: Humana to buy remaining stake in Kindred at home for $5.7 billion

Learn More
May 3, 2021
IDN trends, challenges, and leadership
Our Take: Walmart to acquire on-demand telehealth provider MeMD
Insight
Our Take Newsletter
May 10, 2021

Our Take: Walmart to acquire on-demand telehealth provider MeMD

Learn More
May 10, 2021
Digital health and emerging technologies
Our Take: BD to spin off diabetes business into new publicly traded company
Insight
Our Take Newsletter
May 17, 2021

Our Take: BD to spin off diabetes business into new publicly traded company

Learn More
May 17, 2021
Pharma strategy, engagement, and market access
Our Take: JPMorgan Chase picks up where Haven left off
Insight
Our Take Newsletter
May 24, 2021

Our Take: JPMorgan Chase picks up where Haven left off

Learn More
May 24, 2021
Value-based care and alternative payment models
Our Take: HCA Healthcare to partner with Google Cloud on custom analytics tools
Insight
Our Take Newsletter
June 7, 2021

Our Take: HCA Healthcare to partner with Google Cloud on custom analytics tools

Learn More
June 7, 2021
Digital health and emerging technologies
Our Take: FDA grants accelerated approval to Biogen’s Alzheimer’s drug, creating more controversy
Insight
Our Take Newsletter
June 14, 2021

Our Take: FDA grants accelerated approval to Biogen’s Alzheimer’s drug, creating more controversy

Learn More
June 14, 2021
Pharma strategy, engagement, and market access
Our Take: Beaumont Health and Spectrum Health in talks to form a new 22-hospital health system
Insight
Our Take Newsletter
June 21, 2021

Our Take: Beaumont Health and Spectrum Health in talks to form a new 22-hospital health system

Learn More
June 21, 2021
IDN trends, challenges, and leadership
Our Take: Blues plans fund new startup to address high drug prices
Insight
Our Take Newsletter
June 28, 2021

Our Take: Blues plans fund new startup to address high drug prices

Learn More
June 28, 2021
Pharmacy, PBMs and drug pricing
Our Take: As delta becomes dominant strain, U.S. COVID-19 cases increase nearly 11% in one week
Insight
Our Take Newsletter
July 12, 2021

Our Take: As delta becomes dominant strain, U.S. COVID-19 cases increase nearly 11% in one week

Learn More
July 12, 2021
IDN trends, challenges, and leadership
Our Take: Oral arguments in Pfizer lawsuit renew focus on case that could have industry-wide implications
Insight
Our Take Newsletter
July 19, 2021

Our Take: Oral arguments in Pfizer lawsuit renew focus on case that could have industry-wide implications

Learn More
July 19, 2021
Health policy, CMS initiatives and health economics
Our Take: Health systems, insurers take a ‘wait and see; stance on Aduhelm
Insight
Our Take Newsletter
July 26, 2021

Our Take: Health systems, insurers take a ‘wait and see; stance on Aduhelm

Learn More
July 26, 2021
IDN trends, challenges, and leadership
Stay Aware. Stay Informed.

Want to stay ahead of health care trends?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.